2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours - Aapro, M S; Bohlius, J; Cameron, D A (Eur J Cancer, 2011)
et al.